53278 Federal Register / Vol. 74, No. 199 / Friday, October 16, 2009 / Notices 

Contact Person: Karen Lechter, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3128, 

MSC 7759, Bethesda, MD 20892. 301–496– 

0726. lechterk@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, RFA–OD– 

09–008 BRDG–SPAN and RFA–OD–09–009 

Catalyst ARRA Review Panel 9. 

Date: November 17, 2009. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Aftab A. Ansari, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4108, 

MSC 7814, Bethesda, MD 20892. 301–594– 

6376. ansaria@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research,93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: October 9, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–24976 Filed 10–15–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, 

November 5, 2009, 8 a.m. to November 

6, 2009, 5:00 PM, Hotel Nikko San 

Francisco, 222 Mason Street, San 

Francisco, CA, 94102 which was 

published in the Federal Register on 

October 2, 2009, 74 FR 50975–50977. 

The meeting title has been changed to 

‘‘Fellowship: Cell Biology and 

Development’’. The meeting is closed to 

the public. 

Dated: October 9, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–24975 Filed 10–15–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; NINDS T–32 Review. 

Date: December 1–2, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Argonaut Hotel, 495 Jefferson Street, 

San Francisco, CA 94109. 

Contact Person: Phillip F. Wiethorn, 

Scientific Review Administrator, DHHS/NIH/ 

NINDS/DER/SRB, 6001 Executive Boulevard; 

MSC 9529, Neuroscience Center; Room 3203, 

Bethesda, MD 20892–9529, (301) 496–5388, 

wiethorp@ninds.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: October 9, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–24972 Filed 10–15–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel, IERDA. 

Date: November 13, 2009. 

Time: 10 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Room 5B01, Rockville, 

MD 20852. (Telephone Conference Call). 

Contact Person: Michele C. HindiAlexander, PhD, Division of Scientific 

Review, National Institutes of Health, Eunice 

Kennedy Shriver National Institute of Child 

Health and Human Development, 6100 

Executive Boulevard, Rm. 5B01, Bethesda, 

MD 20892. (301) 435–8382. 

hindialm@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: October 9, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–24966 Filed 10–15–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

Coordinating Center for Infectious 

Diseases (CCID) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

Times and Dates: 

9 a.m.–5 p.m., November 4, 2009 (Working 

Groups). 

8:30 a.m.–3:30 p.m., November 5, 2009 

(Full Board). 

Place: Emory Conference Center, 1615 

Clifton Road, NE., Atlanta, Georgia 30329, 

Telephone: (404) 712–6000. 

Status: Open to the public, limited only by 

the space available. 

Purpose: The Board of Scientific 

Counselors, CCID, provides advice and 


jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 74, No. 199 / Friday, October 16, 2009 / Notices 53279 

guidance to the Director, CDC, and Director, 

CCID, in the following areas: program goals 

and objectives; strategies; program 

organization and resources for infectious 

disease prevention and control; and program 

priorities. 

Matters To Be Discussed: Agenda items 

will include: 

1. Working Groups: Environmental 

Microbiology, research to guide public health 

practice (National Center for Preparedness, 

Detection, and Control of Infectious Diseases; 

National Center for Immunization and 

Respiratory Diseases (NCIRD); and National 

Center for Zoonotic, Vector-Borne, and 

Enteric Diseases (NCZVED) Morning 

Session); Strategic Plan (National Center for 

HIV/AIDS, Viral Hepatitis, STD, and TB 

Prevention); Review of Funding provided 

through the American Recovery and 

Reinvestment Act of 2009 (ARRA) for 

immunization programs funded under 

Section 317 of the Public Health Service Act 

(NCIRD Afternoon Session); Strategic 

Framework and Program Reviews and 

Strategies (NCZVED Afternoon Session). 

2. Full Board: 

H1N1 discussion; announcements and 

introductions; and follow-up on actions 

recommended by the board. 

Agenda items are subject to change as 

priorities dictate. 

Written comments are welcome and should 

be received by the contact person listed 

below prior to the opening of the meeting. 

Contact Person For More Information: 

Harriette Lynch, Office of the Director, CCID, 

CDC, Mailstop E–77, 1600 Clifton Road, NE., 

Atlanta, Georgia 30333, e-mail: 

hlynch@cdc.gov, Telephone (404) 498–2726. 

The Director, Management Analysis and 

Services office has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: October 8, 2009. 

Andre Tyler, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E9–24937 Filed 10–15–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Health Resources and Services 

Administration; CDC/HRSA Advisory 

Committee on HIV and STD Prevention 

and Treatment 

In accordance with section l0(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), CDC and HRSA 

announce the following meeting of the 

aforementioned committee: 

Times and Dates: 

8 a.m.–5:30 p.m., November 2, 2009. 

8 a.m.–3 p.m., November 3, 2009. 

Place: Hyatt Regency Bethesda, 7400 

Wisconsin Avenue (One Bethesda Metro 

Center), Bethesda, Maryland 20814, 

Telephone: (301) 657–1234. 

Status: Open to the public, limited only by 

the space available. The meeting room will 

accommodate approximately 100 people. 

Purpose: This Committee is charged with 

advising the Director, CDC, and the 

Administrator, HRSA, regarding activities 

related to prevention and control of HIV/ 

AIDS and other STDs, the support of health 

care services to persons living with HIV/ 

AIDS, and education of health professionals 

and the public about HIV/AIDS and other 

STDs. 

Matters to be Discussed: Agenda items 

include issues pertaining to: (1) HIV/STD/ 

HCV Prevention, Treatment and Care in 

Federally Qualified Health Centers; (2) 

Biomedical Approaches to HIV Prevention— 

Pre-Exposure Prophylaxis; (3) Federal 

Adolescent Sexual Health Education 

Initiatives; and (4) Role of Surveillance in 

Informing CDC and HRSA Activities. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Margie Scott-Cseh, Coordinating Center for 

Infectious Diseases, Strategic Business Unit, 

CDC, 1600 Clifton Road, NE., Mailstop E–07, 

Atlanta, Georgia 30333, Telephone: (404) 

639–8317. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register Notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: October 8, 2009. 

Andre Tyler, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E9–24934 Filed 10–15–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0664] 

Request for Nominations for Voting 

Members on Public Advisory Panels or 

Committees 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is requesting 

nominations for voting members to 

serve on the Device Good 

Manufacturing Practice Advisory 

Committee, certain device panels of the 

Medical Devices Advisory Committee, 

the National Mammography Quality 

Assurance Advisory Committee, and the 

Technical Electronic Products Radiation 

Safety Standards Committee in the 

Center for Devices and Radiological 

Health. Nominations will be accepted 

for current vacancies and those that will 

or may occur through August 31, 2010. 

FDA has a special interest in ensuring 

that women, minority groups, and 

individuals with disabilities are 

adequately represented on advisory 

committees and, therefore, encourages 

nominations of qualified candidates 

from these groups. 

DATES: Because scheduled vacancies 

occur on various dates throughout each 

year, no cutoff date is established for the 

receipt of nominations. However, when 

possible, nominations should be 

received at least 6 months before the 

date of scheduled vacancies for each 

year, as indicated in this notice. 

ADDRESSES: All nomination for 

membership should be sent 

electronically to CV@OC.FDA.GOV, or 

by mail to Advisory Committee 

Oversight & Management Staff (HF–4), 

5600 Fishers Lane, rm. 14C03, 

Rockville, MD 20857. Information about 

becoming a member on a FDA advisory 

committee can also be obtained by 

visiting FDA’s Web site at http:// 

www.fda.gov/AdvisoryCommittees/ 

default.htm. 

FOR FURTHER INFORMATION CONTACT: For 

specific Committee questions, contact 

the following persons listed in table 1 of 

this document. 


jlentini on DSKJ8SOYB1PROD with NOTICES